24 July 2023
24 July 2023
While artificial intelligence (AI) in medical devices has regulatory boundaries, its use in a medicine’s life cycle is less clear.
Other forms of immunotherapy have progressed rapidly in recent years, but oncolytic viruses remain restricted to the early stages of development.
The approval was based on positive data from two identical Phase III double-blind clinical studies, CAMP-1 and CAMP-2.
Epcoritamab is an investigational IgG1-bispecific antibody developed utilising Genmab's DuoBody technology.
To reduce cash burn, the company has sold off its Asia Pacific operations, except in China, and looks to reduce R&D costs.
The parties will jointly market the RNAi therapeutic in the US region and equally split expenditures and profits.
The FDA grants SN Bioscience’s nano-therapy SNB-101 an orphan drug designation for small cell lung cancer (SCLC).
Janssen has plans to discontinue the CD388 influenza programme as part of pipeline prioritisation, but Cidara plans to continue development.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
